Rapport Therapeutics IPO Price Indicating $18; 8M Share Offering Priced $17
Portfolio Pulse from Benzinga Newsdesk
Rapport Therapeutics has set its IPO price at $18 per share, with an offering of 8 million shares priced at $17 each.
June 07, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rapport Therapeutics has set its IPO price at $18 per share, with an offering of 8 million shares priced at $17 each. This indicates strong initial demand and could lead to positive short-term price movement.
The IPO pricing at $18 per share, with an offering of 8 million shares priced at $17 each, suggests strong initial demand. This is likely to result in positive short-term price movement as investors show interest in the new stock.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100